Published in J Clin Pathol on March 01, 2006
Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology (2011) 2.64
Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci (2012) 2.18
Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci (2012) 2.08
Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol (2008) 0.96
Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol (2010) 0.90
Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol (2011) 0.87
Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol (2010) 0.86
Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World J Gastroenterol (2008) 0.84
Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World J Gastroenterol (2009) 0.81
Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis. World J Hepatol (2012) 0.78
Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis. Eur J Gastroenterol Hepatol (2016) 0.77
Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Dig Dis Sci (2015) 0.77
Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol (2017) 0.75
Juvenile autoimmune hepatitis: Spectrum of the disease. World J Hepatol (2014) 0.75
Liver transplantation and autoimmune hepatitis. Intractable Rare Dis Res (2015) 0.75
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Diagnosis and treatment of autoimmune hepatitis. Hepatology (2002) 3.13
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Autoimmune hepatitis. N Engl J Med (1996) 1.76
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57
Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology (2003) 1.42
De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30
A novel histological lesion in glucocorticoid-responsive chronic hepatitis. Gastroenterology (1997) 1.25
Liver cell death: patterns and mechanisms. Gut (1994) 1.14
Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol (2003) 1.07
Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res (2003) 1.05
Autoimmune hepatitis with centrilobular necrosis. Am J Surg Pathol (2004) 1.02
Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations. Am J Surg Pathol (1995) 0.97
Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology (2001) 0.97
Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl Surg (1995) 0.94
Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol (2002) 0.94
Histologic features in autoimmune hepatitis. Z Gastroenterol (1989) 0.93
Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis. Gut (1997) 0.89
The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol (1994) 0.89
Persistent centrilobular necroses in hepatic allografts. Hum Pathol (1990) 0.88
Central venulitis in liver allografts: considerations of differential diagnosis. Hepatology (2001) 0.86
'Acute' autoimmune hepatitis. Digestion (1986) 0.85
Centrilobular histopathologic changes in liver transplant biopsies. Hum Pathol (2002) 0.83
Etiopathogenesis and prognosis of centrilobular necrosis in hepatic grafts. J Hepatol (1994) 0.81
Prognostic implications of centrilobular necrosis in pediatric liver transplant recipients. Transplantation (1998) 0.79
Central venulitis in the allograft liver: a clinicopathologic study. Transplantation (1997) 0.79
Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients. Transplantation (2002) 0.78
The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation. Transplant Proc (2002) 0.78
Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients. Transplantation (2000) 0.78
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation. Endoscopy (2001) 2.07
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology (1998) 1.91
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor. Lancet (1997) 1.63
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. Br J Surg (2012) 1.60
Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol (2001) 1.50
Association between Helicobacter pylori infection and pancreatic cancer. Oncology (1998) 1.49
Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin Exp Allergy (2014) 1.45
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses. Eur J Cancer (1991) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Scl-86, a marker antigen for diffuse scleroderma. J Clin Invest (1985) 1.43
Antinuclear antibodies in patients with chronic idiopathic autoimmune thrombocytopenia followed 2-30 years. Am J Hematol (1989) 1.42
Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Hepatology (1991) 1.41
ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr (1997) 1.40
[Hepatitis B and C: incidence and regional distribution of hospitalizations in Austria]. Wien Klin Wochenschr (2000) 1.40
Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol (1997) 1.37
Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant (2010) 1.36
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33
Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma (1986) 1.30
Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27
Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr (1983) 1.25
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Detection of circulating immune complexes in alcoholic liver disease. Clin Exp Immunol (1978) 1.21
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol (1987) 1.19
Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer (2002) 1.18
HER 2/neu protein expression in colorectal cancer. BMC Cancer (2006) 1.18
Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem (2000) 1.17
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. Am J Pathol (2000) 1.15
Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci (1989) 1.11
Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol (2008) 1.11
Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol (2003) 1.10
Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol (1999) 1.10
Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration. Br J Cancer (2010) 1.09
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. Aliment Pharmacol Ther (2006) 1.09
The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology (1999) 1.08
Letter: comparing scoring systems and outcome of patients admitted to a liver intensive care unit with severe variceal bleeding. Aliment Pharmacol Ther (2014) 1.07
Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. Bone Marrow Transplant (1990) 1.06
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood (2000) 1.06
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology (1989) 1.06
CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2). J Pathol (2007) 1.05
Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer Detect Prev (2000) 1.02
Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res (1996) 1.02
Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol (1991) 1.02
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. J Clin Virol (2010) 1.01
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology (1998) 1.00
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests. Gut (1988) 1.00
Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol (1995) 0.99
Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology (1996) 0.99
Liver penetration by a duodenal ulcer in a young woman. J Clin Gastroenterol (2001) 0.98
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut (2005) 0.98
Improvement of hepatic encephalopathy treated with flumazenil. Lancet (1988) 0.98
The diagnostic application of specific antiprocollagen sera. II. Analysis of liver biopsies. Int Arch Allergy Appl Immunol (1978) 0.98
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain (2000) 0.98
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment Pharmacol Ther (2012) 0.97
Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol (1995) 0.97
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol (1997) 0.96
Dissociation of immune complexes in tissue sections by excess of antigen. Int Arch Allergy Appl Immunol (1982) 0.96
Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma. Liver (1999) 0.95
Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology (2000) 0.95
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol (1995) 0.95
A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol (1997) 0.94
Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol (2000) 0.94
Wilson's disease presenting in a family with an apparent dominant history of tremor. J Neurol Neurosurg Psychiatry (2001) 0.93
Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis. Acta Med Austriaca (2001) 0.93
An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3. Proc Natl Acad Sci U S A (1994) 0.92
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology (1987) 0.92
Chronic gastrointestinal symptoms in hemodialysis patients. Wien Klin Wochenschr (1998) 0.92
A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis. Clin Exp Immunol (1990) 0.91
Nuclear antigens recognized by antibodies present in liver disease sera. Clin Exp Immunol (1986) 0.91
Energy metabolism in patients with acute and chronic liver disease. Hepatology (1990) 0.91
Color treatment in endoscopic image classification using multi-scale local color vector patterns. Med Image Anal (2011) 0.91
Brain dysfunction in fulminant hepatic failure. J Hepatol (1994) 0.90
Delaunay triangulation-based pit density estimation for the classification of polyps in high-magnification chromo-colonoscopy. Comput Methods Programs Biomed (2012) 0.90
Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun (2005) 0.90